Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b
ArticleAbstract: Polysaccharide-protein conjugates as vaccines have proven to be very effective in preventing HaemophPalabras claves:Autores:Cardoso F., Carmenate T., Chang J., Cosme K., Eugenio Hardy, Fernández-Santana V., Figueroa I., Hernández I., Heynngnezz L., Izquierdo M., Mawas F., Musacchio Lasa A., Peña L., Rodriguez A., Rodriguez M.C., Roy R., Toledo-Romani M.E., Valdés Y., Verez-Bencomo V.Fuentes:scopusCIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo
ArticleAbstract: Protein Kinase CK2 is a serine-threonine kinase frequently deregulated in many human tumors. Here, wPalabras claves:apoptosis, Cancer targeted therapy, Casein kinase 2Autores:Acevedo B.E., Alonso D.F., Ariosa J., Bacardí D.M., Baladron I., Besada-Pérez V., Betancourt L., Castellanos L.R., Cosme K., Cruz M., Díaz A., Falcón-Cama V., Farina H., Garay H.E., Gil J., Gómez D., Gómez R., González L.J., Hernández I., Herrera L., López C., López-Mola E., López-Saura P.A., Marcelo J.L., Mendoza O., Perea-Rodríguez S.E., Perera Y., Puchades Y., Reyes O., Rodriguez A., Sánchez A., Santana A., Serrano J.M., Sigman H., Silva R., Solares M., Thelvia I. Ramos Gómez, Valenzuela-Silva C.M.Fuentes:googlescopusPreclinical safety demonstration of the human recombinant erythropoietin HEBERITRO®
ArticleAbstract: Erythropoietin (EPO) is a glycoprotein that appears in blood as a response to hypoxia, acting on bonPalabras claves:EPREX®, erythropoietin, Preclinical toxicology, safetyAutores:Bacardí D.M., Cosme K., Gutiérrez A., I. Howland-Álvarez, Ivón Howland-Álvarez, Merino N., Pérez-Caballero M., Porras D.N., Suaréz J., Urquiza D., Vázquez A.Fuentes:googlescopus